These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35455008)

  • 1. Post-COVID-19 Condition: Where Are We Now?
    Boaventura P; Macedo S; Ribeiro F; Jaconiano S; Soares P
    Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35455008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is SARS-CoV-2 the only cause of long-COVID?
    Pintos-Pascual I; Moreno-Torres V; Ibánez-Estéllez F; Corrales-Rodriguez P; Treviño A; Corpas M; Corral O; Soriano V; de Mendoza C
    AIDS Rev; 2022 Dec; 24(4):183-196. PubMed ID: 36427058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of COVID-19 on the thyroid gland: an update.
    Scappaticcio L; Pitoia F; Esposito K; Piccardo A; Trimboli P
    Rev Endocr Metab Disord; 2021 Dec; 22(4):803-815. PubMed ID: 33241508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid Dysfunction in Relation to Immune Profile, Disease Status, and Outcome in 191 Patients with COVID-19.
    Lui DTW; Lee CH; Chow WS; Lee ACH; Tam AR; Fong CHY; Law CY; Leung EKH; To KKW; Tan KCB; Woo YC; Lam CW; Hung IFN; Lam KSL
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e926-e935. PubMed ID: 33141191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychiatric aspects of long COVID: A comprehensive review.
    Kubota T; Kuroda N; Sone D
    Psychiatry Clin Neurosci; 2023 Feb; 77(2):84-93. PubMed ID: 36385449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential relationships between COVID-19 and the thyroid gland: an update.
    Naguib R
    J Int Med Res; 2022 Feb; 50(2):3000605221082898. PubMed ID: 35226548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-COVID syndrome. A case series and comprehensive review.
    Anaya JM; Rojas M; Salinas ML; Rodríguez Y; Roa G; Lozano M; Rodríguez-Jiménez M; Montoya N; Zapata E; ; Monsalve DM; Acosta-Ampudia Y; Ramírez-Santana C
    Autoimmun Rev; 2021 Nov; 20(11):102947. PubMed ID: 34509649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-COV-2-related immune-inflammatory thyroid disorders: facts and perspectives.
    Ruggeri RM; Campennì A; Deandreis D; Siracusa M; Tozzoli R; Petranović Ovčariček P; Giovanella L
    Expert Rev Clin Immunol; 2021 Jul; 17(7):737-759. PubMed ID: 34015983
    [No Abstract]   [Full Text] [Related]  

  • 9. Thyroid complications of SARS and coronavirus disease 2019 (COVID-19).
    Speer G; Somogyi P
    Endocr J; 2021 Feb; 68(2):129-136. PubMed ID: 33473054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, pathophysiology, and classification of the neurological symptoms of post-COVID-19 syndrome.
    Carod-Artal FJ; García-Moncó JC
    Neurol Perspect; 2021 Dec; 1():S5-S15. PubMed ID: 36798683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe Fatigue and Memory Impairment Are Associated with Lower Serum Level of Anti-SARS-CoV-2 Antibodies in Patients with Post-COVID Symptoms.
    Molnar T; Varnai R; Schranz D; Zavori L; Peterfi Z; Sipos D; Tőkés-Füzesi M; Illes Z; Buki A; Csecsei P
    J Clin Med; 2021 Sep; 10(19):. PubMed ID: 34640355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID-19 syndrome as a fourth phase of SARS-CoV-2 infection.
    Staffolani S; Iencinella V; Cimatti M; Tavio M
    Infez Med; 2022; 30(1):22-29. PubMed ID: 35350258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-acute COVID-19 condition in Saudi Arabia: A national representative study.
    AlRadini FA; Alamri F; Aljahany MS; Almuzaini Y; Alsofayan Y; Khan A; Albogami N; Abdulrahim M; Almogbil A; Alahmari A
    J Infect Public Health; 2022 May; 15(5):526-532. PubMed ID: 35429791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of headache at onset in SARS-CoV-2 infection is associated with long-term post-COVID headache and fatigue: A case-control study.
    Fernández-de-Las-Peñas C; Gómez-Mayordomo V; Cuadrado ML; Palacios-Ceña D; Florencio LL; Guerrero AL; García-Azorín D; Hernández-Barrera V; Arendt-Nielsen L
    Cephalalgia; 2021 Nov; 41(13):1332-1341. PubMed ID: 34134526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis.
    Soltani S; Tabibzadeh A; Zakeri A; Zakeri AM; Latifi T; Shabani M; Pouremamali A; Erfani Y; Pakzad I; Malekifar P; Valizadeh R; Zandi M; Pakzad R
    Rev Neurosci; 2021 Apr; 32(3):351-361. PubMed ID: 33618441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of the hypothalamic-pituitary-thyroid axis is associated with the severity of prognosis in hospitalized patients with COVID-19.
    Zheng J; Cui Z; Shi N; Tian S; Chen T; Zhong X; Qiu K; Zhang J; Zeng T; Chen L; Li H
    BMC Endocr Disord; 2021 Nov; 21(1):228. PubMed ID: 34781943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The New Entity of Subacute Thyroiditis amid the COVID-19 Pandemic: From Infection to Vaccine.
    Popescu M; Ghemigian A; Vasile CM; Costache A; Carsote M; Ghenea AE
    Diagnostics (Basel); 2022 Apr; 12(4):. PubMed ID: 35454008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.